#151159

Anti-ErbB3 [SGP1]

Cat. #151159

Anti-ErbB3 [SGP1]

Cat. #: 151159

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: ErbB3 (Her3)

Class: Monoclonal

Application: IP ; FACS ; IHC ; IF ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Bill Gullick

Institute: Imperial Cancer Research Fund

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ErbB3 [SGP1]
  • Research fields: Cancer;Cell biology;Cell signaling and signal transduction
  • Clone: SGP1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IP ; FACS ; IHC ; IF ; IP
  • Description: The EGFR family of type I growth factor receptor tyrosine kinases includes EGFR (HER1), c-erbB2 (HER2; neu), c-erbB3 (HER3) and c-erbB4 (HER4). c-erbB3 is normally found in non-dividing differentiated epithelial cells, neurones and hepatocytes. It has approximately 80% prevalence in a wide variety of tumours of the gastro-intestinal tract, and approximately 20% prevalence in breast cancer.
  • Immunogen: c-erb B3 protein from transfected human kidney fibroblasts purified by wheatgerm lectin affinity chromatography
  • Isotype: IgG1 kappa
  • Myeloma used: NS0

Target Details

  • Target: ErbB3 (Her3)
  • Target background: The EGFR family of type I growth factor receptor tyrosine kinases includes EGFR (HER1), c-erbB2 (HER2; neu), c-erbB3 (HER3) and c-erbB4 (HER4). c-erbB3 is normally found in non-dividing differentiated epithelial cells, neurones and hepatocytes. It has approximately 80% prevalence in a wide variety of tumours of the gastro-intestinal tract, and approximately 20% prevalence in breast cancer.

Applications

  • Application: IP ; FACS ; IHC ; IF ; IP

Handling

  • Format: Liquid
  • Concentration: 0.82 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Vollmann-Zwerenz et al. 2010. Cytometry A. 77(4):387-98. PMID: 20151455.
  • Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations.
  • Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types.
  • Rajkumar et al. 1994. Br J Cancer. 70(3):459-65. PMID: 8080731.
  • A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.